Up To 215 Cancer Patients Treated With BrainLAB Image-Guided Patient Positioning System ExacTrac X-Ray 6D
Image-Guided Patient Positioning System ExacTrac X-Ray 6D
Central Arkansas Radiation Therapy Institute installed the ExacTrac X-Ray 6D image-guided radiation therapy system, enabling doctors to pinpoint tumors with increased accuracy and treat a wider variety of indications.
Designed from the ground up to optimize workflow, physicians now have the ability to maximize patient output while also improving treatment outcomes.
Top performing facilities that have selected the ExacTrac X-Ray 6D system accomplish an average of 90 - 100 fractions a week. In comparison to 2006, where an average of 65 fractions per week could be administered, and together with an increased number of ExacTrac X-Ray 6D systems installed, this represents a 117% annual growth in the use of the BrainLAB technology.
CARTI is part of a growing number of healthcare facilities adopting IGRT technology for the improved treatment of malignant and non-malignant tumors. Traditionally, small shifts in patient movement or radiation beam alignment can result in damage to normal tissues surrounding the tumor. BrainLAB IGRT technology uses high-resolution x-rays to pinpoint tumors seconds before treatment, automatically corrects any patient set-up errors and tracks patient movement throughout the procedure.
"The implementation of the BrainLAB ExacTrac X-Ray 6D system makes the advanced treatment technology available for our patients," said Ann Maners, M.D., Radiation Oncologist, CARTI. "Thanks to the high level of accuracy built into BrainLAB technology, we now have the ability to administer more accurate treatments, which should result in fewer complications."
With the arrival of the ExacTrac X-Ray 6D system, patients with tumors that were previously considered not suitable for precision radiotherapy now have new hope due to the technology's ability to precisely deliver a highly focused radiation dose right to the tumor. Greater accuracy means that oncologists can now treat a wider range of indications, including prostate, lung, liver and spine.
"The increasing number of hospitals in the United States that have chosen the ExacTrac X-Ray 6D system is a testament to the technology's efficacy in administering advanced image-guided radiation therapy," said Ralf Schira, Marketing Manager, Oncology, BrainLAB. "The team at CARTI is elevating the standard of care in the region with the acquisition of next-generation patient positioning technology."